The turnover of hepatoma cell γ-glutamyl transferase  by Ding, Jeak L. et al.
Volume 142, number 2 FEBS LETTERS June 1982 
THE TURNOVER OF HEPATOMA CELL 3,-GLUTAMYL TRANSFERASE 
Jeak L. DING, Geoffrey D. SMITH* and Timothy J. PETERS 
Division of Clinical Cell Biology, MRC Clinical Research Centre, Warlord Road, Harrow, Middlesex HA1 3UJ, England 
Received 22 April 1982 
1. Introduction 
7-Glutamyl transferase (5-glutamyl-peptide :amino 
acid 5-glutamyl transferase, EC 2.3.2.2) is a plasma 
membrane-bound enzyme which has been implicated 
in amino.acid transport owing to its ability to catalyse 
the transpeptidation f-t-glutamyl moieties from glu- 
tathione to various amino acid acceptors [1,2]. Ele- 
vated plasma 7-glutamyl transferase (GGT) activity 
has been used as a diagnostic marker for hepatobiliary 
dysfunction [3,4]. Clinical interest has also been gener- 
ated through the possibility of using the enzyme as an 
oncofoetal protein marker of malignancy [5-7]. 
Although several studies have reported a marked 
increase in the enzyme activity during hepatocarcino- 
genesis [7-9], it is not known whether this increased 
activity can be ascribed to an alteration in the half- 
life of the enzyme. 
Previous tudies have shown that aflatoxin-induced 
rat hepatoma GGT has a 16-fold increase in catalytic 
efficiency [10] as compared with the enzyme from 
normal iver [11 ]. Here we show that the hepatoma 
enzyme has a half-life of 24 h, as compared to 3 h for 
the normal iver enzyme [12]. This explains the addi- 
tional increase in the enzyme activity of hepatoma cells. 
2. Materials and methods 
2.1. Inhibition of protein synthesis by cycloheximide 
Rat hepatoma cells OB-1 line) were cultured to 
confluency as in [10] in 100 X 20 mm Falcon culture 
dishes. The conditioned growth medium was replaced 
with 10 ml fresh medium containing 0.5 mM cyclo- 
heximide (Sigma Chemical Co., Poole, Dorset) [13], 
and incubated at 37°C for up to 30 h. Control cells 
were cultured in fresh growth medium alone. Attached 
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cells were harvested in duplicate, after exposure to 
cycloheximide for various times. 
2.2. Inhibition of T-glutamyl transferase by diazotised 
sulphanilic acid 
Diazotised sulphanilic acid (DSA) [14] is a non- 
penetrating reagent which covalently inactivates 
plasma-membrane ectoenzymes including GGT [ 10]. 
The confluent monolayer of cells was rinsed twice 
with phosphate-buffered saline (~BS), and irreversible 
inactivation of the GGT activity was carried out by 
incubating the cells at 37°C for 10 min in 10 ml PBS 
containing 3 mM DSA. Control cells were treated in 
the same way but with 10 ml PBS alone. Morphological 
studies howed that treatment of these cells, with 
between 1-10 mM DSA, did not affect heir viability. 
At the end of the treatment, the cells were rinsed 
twice with PBS before fresh growth medium was added. 
Incubation at 37°C was resumed, during which the 
cells were harvested, in duplicate, at time intervals of 
up to 70 h. 
2.3.Inhibition of 7-glutamyl transferase by AT-125 
AT- 125, (L- [aS,5S]-a-amino-3-chloro-4,5-dihydro- 
5-isoxazoleacetic acid) (donated by Dr T. Connors, 
MRC Toxicology Unit, Carshalton) is a glutamine 
analog which causes pecific and irreversible inhibition 
of GGT [15]. Preliminary studies howed that a maxi- 
mum of 85-95% of the enzyme activity was inhibited 
by incubation with 450 wnol AT-125/1 at 37°C for 
30 min. Treatment of the cultured ceils under these 
conditions was carried out as described for the DSA 
inhibition studies. The control and treated cells were 
harvested in duplicate at time intervals of up to 40 h. 
2.4. Determination of specific activity of 7-glutamyl 
transferase 
The harvested cells were washed twice in PBS and 
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centrifuged at 250 × g for 10 min. The enzyme was 
solubilised with 0.5% Triton X-100 in PBS and GGT 
activity was measured as in [16]. DNA was assayed 
fluorimetrically in [ 17] with calf thymus DNA 
(type I, Sigma) as standard. 
3. Results 
Treatment of hepatoma cells in culture with cyclo- 
heximide resulted in a progressive detachment of the 
ceils from the dish. The specific activity of GGT 
(-'-2000 mUnits/mg DNA) of the attached cells under- 
went a first-order decay. Fig.1 shows the rate of dis- 
appearance of GGT activity with tw2 = 23 h. An 
apparent lag period of ~10 h was observed. 
Treatment of the cells with DSA resulted in marked 
loss of GGT activity. Following removal of the inhibi- 
tor, GGT activity returned to normal evels as new 
enzyme was synthesized. The rate of recovery of the 
cellular GGT level followed first-order kinetics with a 
tu2 = 22 h (fig.2). There was an initial lag period of 
8-10 h preceeding the reappearance of GGT activity. 
The rate of reappearance of GGT after inactivation of 
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Fig.1. Inhibition of protein synthesis n cultured hepatoma 
cells, by 0.5 mM cycloheximide. Semilogarithmic plot of the 
decrease in specific activity of ~/-glutamyl transferase (GGT) 
against time of treatment with cycloheximide: C, specific 
activity of control culture; T, specific activity of treated cul- 
ture. The slope is k/2.303, where k is the first-order rate con- 
stant with the units of time -1. The half-like (t~/=) of 23 h for 
GGT was calculated from: t~ a = 0.693/k. 
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Fig.2. Inhibition of ~-glutamyl transferase (GGT) in cultured 
hepatoma ceils by 0.3 mM diazotized sulphanilic acid. Semi- 
logarithmic plot of the resynthesis of GGT with time, in the 
treated hepatoma cells: C, specific activity of control cells; 
T, specific activity of treated cells. From the rate of increase 
in the enzyme specific activity, the half-life (tw2) of 22 h for 
GGT was calculated as in fig.1. 
pre-existing enzyme with AT-125 followed zero-order 
kinetics, with tw2 __- 27 h (fig.3). There was no appar- 
ent lag period for the resynthesis of GGT following 
the withdrawal of AT-125. 
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Fig.3. Specific inhibition of "y-glutamyl transferase (GGT) in 
cultured hepatoma ceils, by 450 ~m L-[oS,5S]-~-amino-3- 
chloro-4,5-dihydro-5-isoxazolacetic acid (AT-125). Rate of 
resynthesis (C-T) plotted against time, where C is specific 
activity of control, and T is the specific activity of the AT-125 
treated cells. The slope (k) is the zero-order rate constant of 
the resynthesis of GGT. The half-life (tu2) of 27 h for GGT 
was obtained from the formula: tua = C/2k. 
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4. Discussion 
Here, the rate of breakdown of GGT in the cultured 
hepatoma cells was followed during the inhibition of 
protein synthesis by cyclohexirnide. Also, the rate of 
synthesis of the enzyme was monitored after covalent 
inactivation of the pre-existing levels of GGT with 
DSA or AT-125. Because the try-values , as determined 
by measurements of both synthesis and degradation 
rates, are similar, it is suggested that these techniques 
give an accurate reflection of the half-life of the 
enzyme. 
The lag period observed in cycloheximide studies 
is probably the time taken for this compound to 
exert its effect on protein synthesis and translocation 
systems within the cell and has been similarly observed 
in cultured fibroblasts [13]. Following the inhibition 
of GGT with DSA, a similar lag period was apparent. 
Since DSA is a non-specific inhibitor, it would be 
expected to inactivate other ecto-plasma membrane 
enzymes. This may lead to disturbance, or loss, of 
some other membrane-bound proteins that are essen- 
tial for metabolite transport. However, the lag period 
could be partly explained by the time taken for the 
processing of newly formed proteins from rough endo- 
plasmic reticulum to the Golgi complex with the sub- 
sequent insertion of the glycoproteins into plasma 
membrane. The absence of a lag period during the 
turnover studies with AT-125, a highly selective inhib- 
itor of GGT, suggests that the lag phase observed with 
DSA relates to inactivation of non-GGT proteins. 
The synthesis of proteins is generally thought of 
as a zero order process, and indeed the recovery of 
GGT activity after inactivation with AT-125 follows 
this pattern. However, after inactivation with DSA, 
recovery follows first-order kinetics. This may result 
from a limiting concentration of certain amino acids, 
since the amino acid transport mechanisms would 
also be expected to be inactivated by this reagent. 
The half-life derived from these studies is shorter 
than the 100 h reported for plasma membrane glyco- 
proteins of a cloned line of cultured hepatoma cells 
[18]. However, as compared with the half-life of 3 h 
obtained for the normal rat liver GGT [12], the aria- 
toxin-induced GGT has a substantially prolonged 
(8-fold) half-life. The longer life-span of the hepatoma 
cell GGT might be explained by the increase in the 
sialylation of the enzyme [10], which is a feature of 
hepatocarcinogenesis [ 19]. By analogy with circulating 
glycoproteins [20], this modification may protect he 
enzyme and delay its clearance rate. 
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